Search research articles
Contact Us
Filters
Showing results (21-30 of 80) with videos related to
Page
of 8
Sort By:
BMC Endocrine Disorders
|
August 28, 2020
New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report
Hiroshi Yamada, Fumitaka Okajima, Takeshi Onda, et al.
Journal of Diabetes Investigation
|
October 21, 2016
Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal-bolus insulin therapy: An open-label, single-center, parallel, randomized control study
Fumitaka Okajima, Tomoko Nagamine, Yuko Nakamura, et al.
Diabetologia
|
June 21, 2020
Leptin production capacity determines food intake and susceptibility to obesity-induced diabetes in Oikawa-Nagao Diabetes-Prone and Diabetes-Resistant mice
Akira Asai, Mototsugu Nagao, Koji Hayakawa, et al.
Regulatory Peptides
|
February 1, 2005
Insulin-like growth factor-I down-regulates ghrelin receptor (growth hormone secretagogue receptor) expression in the rat pituitary
Jun Kamegai, Hideki Tamura, Takako Shimizu, et al.
Endocrinology
|
August 24, 2002
Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats
Hideki Tamura, Jun Kamegai, Takako Shimizu, et al.
Endocrinology
|
November 26, 2002
Role of ghrelin in streptozotocin-induced diabetic hyperphagia
Shinya Ishii, Jun Kamegai, Hideki Tamura, et al.
Journal of Diabetes Investigation
|
November 3, 2017
Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes
Shunsuke Kobayashi, Mototsugu Nagao, Akira Asai, et al.
Journal of Diabetes Investigation
|
May 30, 2020
Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism
Mikiko Okazaki-Hada, Ayako Moriya, Mototsugu Nagao, et al.
Patient Preference and Adherence
|
September 15, 2021
Risk Preferences, Rationality of Choices, and Willingness to Pay for Preventive Medicine in Patients with Graves' Thyrotoxicosis
Naoya Emoto, Mikiko Okazaki-Hada, Yuji Yamaguchi, et al.
Cardiovascular Diabetology
|
February 8, 2024
Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study
Mototsugu Nagao, Jun Sasaki, Kyoko Tanimura-Inagaki, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 80) with videos related to
Sort By:
Page
of 8
BMC Endocrine Disorders
|
August 28, 2020
New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report
Hiroshi Yamada, Fumitaka Okajima, Takeshi Onda, et al.
Journal of Diabetes Investigation
|
October 21, 2016
Preventive effect of ipragliflozin on nocturnal hypoglycemia in patients with type 2 diabetes treated with basal-bolus insulin therapy: An open-label, single-center, parallel, randomized control study
Fumitaka Okajima, Tomoko Nagamine, Yuko Nakamura, et al.
Diabetologia
|
June 21, 2020
Leptin production capacity determines food intake and susceptibility to obesity-induced diabetes in Oikawa-Nagao Diabetes-Prone and Diabetes-Resistant mice
Akira Asai, Mototsugu Nagao, Koji Hayakawa, et al.
Regulatory Peptides
|
February 1, 2005
Insulin-like growth factor-I down-regulates ghrelin receptor (growth hormone secretagogue receptor) expression in the rat pituitary
Jun Kamegai, Hideki Tamura, Takako Shimizu, et al.
Endocrinology
|
August 24, 2002
Ghrelin stimulates GH but not food intake in arcuate nucleus ablated rats
Hideki Tamura, Jun Kamegai, Takako Shimizu, et al.
Endocrinology
|
November 26, 2002
Role of ghrelin in streptozotocin-induced diabetic hyperphagia
Shinya Ishii, Jun Kamegai, Hideki Tamura, et al.
Journal of Diabetes Investigation
|
November 3, 2017
Severity and multiplicity of microvascular complications are associated with QT interval prolongation in patients with type 2 diabetes
Shunsuke Kobayashi, Mototsugu Nagao, Akira Asai, et al.
Journal of Diabetes Investigation
|
May 30, 2020
Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism
Mikiko Okazaki-Hada, Ayako Moriya, Mototsugu Nagao, et al.
Patient Preference and Adherence
|
September 15, 2021
Risk Preferences, Rationality of Choices, and Willingness to Pay for Preventive Medicine in Patients with Graves' Thyrotoxicosis
Naoya Emoto, Mikiko Okazaki-Hada, Yuji Yamaguchi, et al.
Cardiovascular Diabetology
|
February 8, 2024
Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study
Mototsugu Nagao, Jun Sasaki, Kyoko Tanimura-Inagaki, et al.
Page
of 8